NEW YORK, Aug. 10, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan, Inc. (NYSE:AGN) from February 25, 2014 through April 21, 2014, inclusive (the “Class Period”) of the important August 29, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Allergan investors under the federal securities laws.
To join the Allergan class action, go to http://rosenlegal.com/cases-1156.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The class action asserts claims under Sections 14(e), 20A and 20(a) of the Securities Exchange Act of 1934 arising from the 2014 attempted acquisition of Allergan by Valeant and its affiliates. The complaint alleges that certain Defendants traded on material non-public information regarding the proposed acquisition, and as a result, Class members that sold Allergan call options, purchased Allergan put options and/or sold Allergan equity forward contracts during the Class Period did so at prices that did not reflect the material nonpublic information known to Defendants. In this action, Plaintiff seeks an award of damages, and prejudgment interest, to Plaintiff and other Class members.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 29, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1156.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 



